Bristol-Myers Squibb Co (BMY) Financials
Bristol-Myers Squibb Co (BMY) Historical Financial Statements and Key Metrics for 1989 - 2020
Full Bristol-Myers Squibb Co financials for 1989 - 2020 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Bristol-Myers Squibb Co Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2020-Sep-30 | 10,540 | 8,038 (76.3 %) | 1,342 (21.4 %) | 1,872 (17.8 %) | 4,639 | 0.82 |
| 2020-Jun-30 | 10,129 | 7,430 (73.4 %) | 891 (16.1 %) | -85 (-0.8 %) | 4,662 | -0.04 |
| 2020-Mar-31 | 10,781 | 7,119 (66.0 %) | 783 (-2.8 %) | -775 (-7.2 %) | 3,380 | -0.34 |
| 2019-Dec-31 | 7,945 | 5,579 (70.2 %) | 227 (2.9 %) | -1,056 (-13.3 %) | 1,390 | -0.55 |
| 2019-Sep-30 | 6,007 | 4,221 (70.3 %) | 3,170 (52.8 %) | 1,353 (22.5 %) | 1,716 | 0.83 |
| 2019-Jun-30 | 6,273 | 4,516 (72.0 %) | 1,714 (27.3 %) | 1,432 (22.8 %) | 2,061 | 0.87 |
| 2019-Mar-31 | 5,920 | 4,070 (68.8 %) | 1,799 (30.4 %) | 1,710 (28.9 %) | 2,189 | 1.04 |
Full historical income statements for 1989 - 2020 is included in the
US Historical Financials dataset.
Bristol-Myers Squibb Co Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2020-Sep-30 | 125,536 | 75,306 | 44,949 | 50,158 | 21,281 |
| 2020-Jun-30 | 128,076 | 78,916 | 47,510 | 49,094 | 21,793 |
| 2020-Mar-31 | 129,285 | 79,308 | 47,530 | 49,911 | 18,322 |
| 2019-Dec-31 | 129,944 | 78,346 | 46,733 | 51,598 | 15,393 |
| 2019-Sep-30 | 57,433 | 39,785 | 24,959 | 17,648 | 32,542 |
| 2019-Jun-30 | 55,163 | 39,114 | 24,978 | 16,049 | 29,357 |
| 2019-Mar-31 | 34,834 | 19,616 | 6,016 | 15,218 | 8,764 |
Full historical balance sheet data for 1989 - 2020 is included in the
US Historical Financials dataset.
Bristol-Myers Squibb Co Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2020-Sep-30 | 2,219 | 0 | 0 | 2,066 |
| 2020-Jun-30 | 4,269 | 0 | 0 | 4,138 |
| 2020-Mar-31 | 3,894 | 0 | 0 | 3,708 |
| 2019-Dec-31 | 2,038 | -12,036 | -7,677 | 1,787 |
| 2019-Sep-30 | 2,556 | 491 | -941 | 2,366 |
| 2019-Jun-30 | 2,083 | 715 | 18,268 | 1,892 |
| 2019-Mar-31 | 1,390 | 1,060 | -2,029 | 1,186 |
Full historical cash flow data for 1989 - 2020 is included in the
US Historical Financials dataset.
Bristol-Myers Squibb Co Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2020-Sep-30 | 136,075 | 161,589 | 12.91 | 72.69 | 2.71 |
| 2020-Jun-30 | 132,057 | 155,835 | 13.04 | -1,553.61 | 2.69 |
| 2020-Mar-31 | 123,883 | 153,415 | 11.49 | -159.85 | 2.48 |
| 2019-Dec-31 | 120,332 | 151,956 | 15.15 | -113.95 | 2.33 |
| 2019-Sep-30 | 80,311 | 74,781 | 13.37 | 59.36 | 4.55 |
| 2019-Jun-30 | 72,628 | 69,202 | 11.58 | 50.72 | 4.53 |
| 2019-Mar-31 | 73,411 | 72,092 | 12.40 | 42.93 | 4.82 |
Full historical valuation and operating metrics for 1989 - 2020 are included in the
US Historical Financials dataset.